Europe Surgical Sealants And Adhesives Market

Europe Surgical Sealants and Adhesives Market Size & Growth (2023 to 2028):

According to the report, the Europe Surgical Sealants and Adhesives Market size is valued at USD 673.56 million in 2023 and is projected to grow at a CAGR of 9.7 % to reach USD 1070.06 million by 2028 during the forecast period 2023 to 2028.

The increasing incidence of diseases such as cancer, obesity, and cardiovascular diseases are majorly driving the European surgical sealants and adhesives market—also, the rising incidence of trauma and increased rate of surgeries fueling the market growth.

The growing number of accidents and the increase in sport-related injuries has increased the demand for surgical procedures across the region during the forecast period. 

The Y-O-Y growing geriatric population significantly contributes to the surgical sealants and adhesives market. In addition, because the senior population is more suspectible to diabetes, trauma cases, and CVDs, increasing demand for blood loss control in patients is expected to drive the market growth.

 In addition, technological advancements with practical product innovation through CE marking and FDA approvals are projected to furnish the market with lucrative growth opportunities.

Surgical procedures are often followed by a risk of injury, severe bleeding, or tissue damage. In addition, diabetic patients should be cautious because the risk of complications during and after surgery is considerably higher. Additionally, the demand for surgical sealants is primarily driven by an increasing prevalence of invasive surgery. 

Traditionally, sutures/threads/staples are used to seal wounds and pose serious threats such as tissue damage, infection, and delayed tissue repair. Due to the rapid development of technology, conventional approaches are being replaced by surgical sealants, leading to the flourishing growth of the industry. Additionally, recent advances have led to biocompatible adhesives, which have reduced complications associated with invasive surgery. It also allows the natural movement of tissues without any intervention on the functioning of the organs.

According to the Centers for Disease Control and Prevention (CDC), approximately 4.5 million people aged 15 and up have been hospitalized due to a sports injury (as defined by the EU IDB catalog of sports). As per the data, the 15-24-year-old age group accounts for around 25% of all sports injuries. Furthermore, a significant sporting category in Europe, team ball sports, accounts for over 40% of all hospital-treated sports injuries. Surgical procedures often come with a risk of wound infection, excessive bleeding, or tissue damage. In addition, diabetic patients should be more careful, as the risk of complications during and after surgery is significantly higher in their case.

However, the high cost of approval and inadequate reimbursement policies are limiting factors for the market. At the same time, lack of growing awareness and lower disposable income is challenging to factor for the market. 

Moreover, other factors like the extensive clinical data requirements for product launches and the availability of substitutes for surgical adhesives and sealants will restrain the market growth. Minimally invasive surgery, for example, is an option because it only requires a small incision to perform, eliminating the problems associated with bleeding and air leakage.

This research report on the Europe Surgical Sealants and Adhesives Market has been segmented and sub-segmented into the following categories.

By Product:

• Natural/Biological Surgical Sealants & Adhesives
  • Polypeptide/Protein-based Sealants & Adhesives
  • Polysaccharide-based Sealants & Adhesives
• Synthetic & Semisynthetic Sealants and Adhesives
  • Cyanoacrylates
  • Polyethylene Glycol-based Hydrogel
  • Urethane-based Adhesives

By Indication: 

• Tissue Sealing & Hemostasis
• Tissue Engineering

By Application: 

• Central Nervous System Surgeries
• General Surgeries
• Cardiovascular Surgeries
• Orthopedic Surgeries
• Cosmetic Surgeries
• Ophthalmic Surgeries
• Urological Surgeries
• Pulmonary Surgeries

By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Geographically, the Europe is anticipated to account for the second-largest share of the surgical sealants and adhesives market. The regional market growth is linked to the increasing importance of surgical care in the public health healthcare policies in the region, supportive government policies, and technological advancements in the healthcare sector. As a result, Germany, the UK, Italy, and France significantly contribute to the regional surgical sealants and adhesives market. 

The UK surgical sealants and adhesives market is projected to register a prominent share in the sealants and adhesives market during the forecast period. The prominence of key market players, the development of bio-based adhesives, and the rising demand for bonded cement for composite materials are all expected to drive market expansion. In addition, consumption in various sectors such as healthcare, construction, or packaging and increasing investment in bonds will drive the market growth. 

In addition, the German Surgical Adhesives and Sealants market is expected to witness rapid growth during the forecast period, supported by growing health awareness, developing medical tourism, favorable reimbursement policies, and demand for quality health care; this is expected to drive the growth of this market during the forecast period.

Moreover, the lower interest rates, a rise in real disposable income, and significant investments from the French and Denmark governments all contribute to growth.

KEY MARKET PLAYERS

Prominent Companies dominating the Europe Surgical Sealants and Adhesives Market Profiled in the Report are CryoLife, Inc, Johnson & Johnson, Ethicon, Inc., Baxter International, Inc, and C.R. Bard, Inc, Cohera Medical, Inc. Ocular Therapuetix, Inc, Vivostat A/S and Sealantis Ltd, Medtronic plc, Sanofi Group, B. Braun Melsungen AG.,